Addex Therapeutics operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Addex Therapeutics with three other
pharmaceutical manufacturers in Europe:
sales of 6.13 million Euro [US$6.80 million]
of which 91%
was Operating segment -Rest of the world),
Biotec Pharmacon ASA
(66.77 million Norwegian Kroner [US$7.43 million]
of which 51%
was Enzymes), and
(6.55 million Swiss Francs [US$6.69 million]
of which 100%
was Pharma Business).
Sales increased substantially in 2018:
Addex Therapeutics reported sales of 6.70 million Swiss Francs (US$6.85 million)
December of 2018.
increase of 1,240.8%
versus 2017, when the company's sales were 499,894.00 Swiss Francs.
This was the third consecutive year of growth at Addex Therapeutics.